A cross-sectional study to evaluate the effectiveness of XALKORI Patient Information Brochure among non-small cell lung cancer (NSCLC) patients receiving XALKORI treatment in Europe

01/09/2014
02/07/2024
EU PAS number:
EUPAS7393
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A8081050_PROTOCOL Crizotinib Patient Survey_25Mar2014

English (957.71 KB - PDF) View document
Updated protocol

A8081050_PROTOCOL AMENDMENT 2_Crizotinib Patient Survey_30 March 2015 Clean_Register

First published: 22/02/2024
English (354.13 KB - PDF) View document
Study results
Study results

Crizotinib A8081050 NI Study Report

English (4.33 MB - PDF) View document
Study report
Other information